Crescendo Biologics Ltd.
2 clinical trials · Sponsor
◉ Watch Crescendo Biologics Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions (NCT05836623) | Crescendo Biologics Ltd. | 2022-12-20 |
| Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. (NCT04839991) | Crescendo Biologics Ltd. | 2021-06-08 |
Track Crescendo Biologics Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.